MUMBAI, India, Feb. 13 -- Intellectual Property India has published a patent application (202611001575 A) filed by Surbhi Joshi; Prof. Niraj Kumar; Sharda Sharma; Sandeep Kumar; Naresh Chandra Singh; and Pooja Bisht, Dehradun, Uttarakhand, on Jan. 7, for 'structured progressive resistance exercise protocol for early cardiac rehabilitation patients.'
Inventor(s) include Surbhi Joshi; Prof. Niraj Kumar; Sharda Sharma; Sandeep Kumar; Naresh Chandra Singh; and Pooja Bisht.
The application for the patent was published on Feb. 13, under issue no. 07/2026.
According to the abstract released by the Intellectual Property India: "The present invention relates to a structured progressive resistance exercise protocol specifically designed for implementation during the first seven days of cardiac rehabilitation following acute cardiac events. The protocol addresses the critical need for early muscle preservation while maintaining stringent safety standards through comprehensive monitoring. The invention comprises a sequential seven-day program beginning with isometric quadriceps contractions during intensive care unit phase on days one and two, progressing to dynamic knee extension exercises against gravity during post-intensive care unit phase on days three through seven. Exercise intensity is precisely regulated using percentage of one-repetition maximum calculations and Borg Rating of Perceived Exertion scale monitoring. The protocol incorporates the validated two-for-two rule for systematic progression, clearly defined eligibility and exclusion criteria for appropriate patient selection, and comprehensive discontinuation criteria including abnormal hemodynamic responses and exercise-induced complications. The invention represents a significant advancement in cardiac rehabilitation by providing the first standardized evidence-based approach to implementing resistance training during the critical first week of recovery, thereby preventing rapid muscle deconditioning that occurs during hospitalization while ensuring patient safety through continuous monitoring and individualized progression based on tolerance."
Disclaimer: Curated by HT Syndication.
